UC San Diego spinout awarded up to $15M for nanosponge ...

The Vancouver, WA-based biotech is working on a more efficient way to manufacture proteins — from full-length antibodies to insulin — using...

Endpoints News | 2020-10-21 11:06:01

SparingVision raises $52M to kick off long journey for a next-gen ...

The Vancouver, WA-based biotech is working on a more efficient way to manufacture proteins — from full-length antibodies to insulin — using...

Endpoints News | 2020-10-20 22:06:01

The Vancouver, WA-based biotech is working on a more efficient way to manufacture proteins — from full-length antibodies to insulin — using...

Endpoints News | 2020-10-20 19:06:01

The Vancouver, WA-based biotech is working on a more efficient way to manufacture proteins — from full-length antibodies to insulin — using...

Endpoints News | 2020-10-20 16:06:01

The Vancouver, WA-based biotech is working on a more efficient way to manufacture proteins — from full-length antibodies to insulin — using...

Endpoints News | 2020-10-20 15:06:01

The Vancouver, WA-based biotech is working on a more efficient way to manufacture proteins — from full-length antibodies to insulin — using...

Endpoints News | 2020-10-20 15:06:01

The Vancouver, WA-based biotech is working on a more efficient way to manufacture proteins — from full-length antibodies to insulin — using...

Endpoints News | 2020-10-20 15:06:01

The Vancouver, WA-based biotech is working on a more efficient way to manufacture proteins — from full-length antibodies to insulin — using...

Endpoints News | 2020-10-20 12:06:01

The Vancouver, WA-based biotech is working on a more efficient way to manufacture proteins — from full-length antibodies to insulin — using E. coli.

Endpoints News | 2020-10-17 00:06:01

The Vancouver, WA-based biotech is working on a more efficient way to manufacture proteins — from full-length antibodies to insulin — using E. coli.

Endpoints News | 2020-10-16 00:06:01